INDP Earnings

Quarterly EPS
$-9.04
Q3 2024
$-4.08
Q4 2024
$-9.11
Q1 2025
$-9.09
Q2 2025
$-2.98
Q3 2025
$-4.52
Q4 2025
$-0.23
Q1 2026
$-0.02
Q2 2026
Latest RevenueN/A
Latest Net Income-1794863
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.020-1794863+99.8%
Q1 2026-$0.230-2541070+97.5%
Q4 2025-$4.520-8112450-10.8%
Q3 2025-$2.980-2975117+67.0%
Q2 2025-$9.090-5228919+30.9%
Q1 2025-$9.110-4532430+27.7%
Q4 2024-$4.080-4131047+69.4%
Q3 2024-$9.040-3069036+31.3%
Q2 2024-$13.160-4015267
Q1 2024-$12.600-3806677
Q4 2023-$13.340-4002780
Q3 2023-$13.160-3922388
Indaptus Therapeutics (INDP) — Earnings